Skip to main content
Premium Trial:

Request an Annual Quote

Peter Hackett, Michael Raymont, Richard Normandin


Peter Hackett, formerly vice president of research and technology development at Canada’s National Research Council, has been named vice president of research for life sciences and information technology, the agency announced last week. The new responsibility follows two new executive appointments at the NRC: Michael Raymont, who was tapped as vice president of technology and industry support; and Richard Normandin, appointed as vice president of research for physical sciences and engineering.

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.